Autoimmune encephalitis as differential diagnosis of infectious encephalitis

Current Opinion in Neurology

Volumn 27, Issue 3, 2014, Pages 361-368

  Armangue, Thaís ^a   Leypoldt, Frank ^b   Dalmau, Josep ^a,b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

autoimmune encephalitis; herpes simplex encephalitis; immunotherapy; neuronal surface antibodies; viral encephalitis

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; AMPA RECEPTOR; AQUAPORIN 4; CONTACTIN; CONTACTIN ASSOCIATED PROTEIN LIKE 2; DIPEPTIDYL PEPTIDASE; DIPEPTIDYLPEPTIDASE LIKE PROTEIN 6; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; IMMUNOGLOBULIN; LEUCINE RICH GLIOMA INACTIVATED PROTEIN 1; MEMBRANE ANTIGEN; METABOTROPIC RECEPTOR 5; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RITUXIMAB; UNCLASSIFIED DRUG; ALPHA-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID SUBTYPE GLUTAMATE RECEPTOR, HUMAN; AUTOANTIBODY; CNTNAP2 PROTEIN, HUMAN; DPP6 PROTEIN, HUMAN; GLUTAMATE RECEPTOR; GRM5 PROTEIN, HUMAN; LGI1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; POTASSIUM CHANNEL; PROTEIN;

ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE ENCEPHALITIS; AUTOIMMUNITY; CELL SURFACE; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DUODENUM BIOPSY; ENCEPHALITIS; FOLLOW UP; HERPES SIMPLEX ENCEPHALITIS; HERPES ZOSTER ENCEPHALITIS; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE LIPODYSTROPHY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PERNICIOUS ANEMIA; PLEOCYTOSIS; POSTERIOR FOSSA; PRODROMAL SYMPTOM; REVIEW; VARICELLA ZOSTER VIRUS; VIRUS ENCEPHALITIS; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; BRAIN; BRAIN DISEASES; ENCEPHALITIS, HERPES SIMPLEX; HASHIMOTO DISEASE; IMMUNOLOGY; PATHOLOGY; TUBERCULOSIS, CENTRAL NERVOUS SYSTEM;

ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; AUTOANTIBODIES; BRAIN; BRAIN DISEASES; DIAGNOSIS, DIFFERENTIAL; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; ENCEPHALITIS; ENCEPHALITIS, HERPES SIMPLEX; HASHIMOTO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; POTASSIUM CHANNELS; PROTEINS; RECEPTOR, METABOTROPIC GLUTAMATE 5; RECEPTORS, GABA-A; RECEPTORS, GLUTAMATE; TUBERCULOSIS, CENTRAL NERVOUS SYSTEM;

EID: 84900424424     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0000000000000087     Document Type: Review

References (57)

1. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006; 43:1565-1577.
2. Mailles A, Stahl JP. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009; 49:1838-1847.
3. Koskiniemi M, Rantalaiho T, Piiparinen H, et al. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol 2001; 7:400-408.
4. Lancaster E, Dalmau J. Neuronal autoantigens: pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012; 8:380-390.
5. Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009; 28:1421-1429.
6. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10:835-844.
7. Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54:899-904.
8. Kneen R, Michael BD, Menson E, et al. Management of suspected viral encephalitis in children-Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect 2012; 64:449-477.
9. Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 2013; 57:1114-1128.
10. Panzer JA, Gleichman AJ, Lynch DR. Glutamatergic autoencephalitides: an emerging field. J Neural Transm 2014. [Epub ahead of print]
11. Pruss H, Finke C, Holtje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012; 72:902-911.
12. Armangue T, Leypoldt F, Malaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 2014; 75:317-323.
13. Thomas L, Mailles A, Desestret V, et al. Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis. J Infect 2013. [Epub ahead of print]
14. Gregoire SM, van Pesch V, Goffette S, et al. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J Neurol Neurosurg Psychiatry 2006; 77:938-942.
15. Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain 2004; 127:1831-1844.
16. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65:424-434.
17. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010; 9:776-785.
18. Hoftberger R, Titulaer MJ, Sabater L, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 2013; 81:1500-1506.
19. Lancaster E, Martinez-Hernandez E, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 2011; 77:1698-1701.
20. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12:157-165.
21. Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an auto antigen of encephalitis and neuromyotonia. Ann Neurol 2011; 69:303-311.
22. Boronat A, Gelfand JM, Gresa-Arribas N, et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 2012; 73:120-128.
23. Petit-Pedrol M, Armangue T, Xiaoyu P, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014; 13:276-286.
24. Elbers JM, Bitnun A, Richardson SE, et al. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics 2007; 119:e399-e407.
25. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75:1135-1140.
26. Titulaer MJ, Soffietti R, Dalmau J, et al. Screening for tumours in para-neoplastic syndromes: report of an EFNS task force. Eur J Neurol 2011; 18:19-23.
27. Shavit YB, Graus F, Probst A, et al. Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis. Ann Neurol 1999; 45:255-258.
28. Castle J, Sakonju A, Dalmau J, Newman-Toker DE. Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipple's disease. Nat Clin Pract Neurol 2006; 2:566-572.
29. Peltola J, Kulmala P, Isojarvi J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000; 55:46-50.
30. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7:1091-1098.
31. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66:11-18.
32. Armangue T, Titulaer MJ, Malaga I, et al. Pediatric anti-N-methyl-D- aspartate receptor encephalitis: clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013; 162:850-856.
33. Viaccoz A, Desestret V, Ducray F, et al. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 2014; 82: 556-563.
34. Titulaer MJ, Dalmau J. Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men. Neurology 2014; 82:550-551.
35. Laothamatas J, Sungkarat W, Hemachudha T. Neuroimaging in rabies. Adv Virus Res 2011; 79:309-327.
36. Ward KN, Leong HN, Thiruchelvam AD, et al. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 2007; 45:1298-1304.
37. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61:25-36.
38. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123:1481-1494.
39. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133:2734-2748.
40. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011; 69:892-900.
41. Andrade DM, Tai P, Dalmau J, Wennberg R. Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology 2011; 76:1355-1357.
42. Ohkawa T, Fukata Y, Yamasaki M, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 2013; 33:18161-18174.
43. Balint B, Jarius S, Nagel S, et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology 2014. [Epub ahead of print]
44. Carr I. The Ophelia syndrome: memory loss in Hodgkin's disease. Lancet 1982; 1:844-845.
45. Mat A, Adler H, Merwick A, et al. Ophelia syndrome with metabotropic glutamate receptor 5 antibodies in CSF. Neurology 2013; 80:1349-1350.
46. Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 2012; 72:241-255.
47. Dale RC, Merheb V, Pillai S, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 2012; 135:3453-3468.
48. Ben-Pazi H, Stoner JA, Cunningham MW. Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea. PLoS One 2013; 8:e73516.
49. Leypoldt F, Titulaer MJ, Aguilar E, et al. Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: a case report. Neurology 2013; 81:1637-1639.
50. Hacohen Y, Deiva K, Pettingill P, et al. N-Methyl-D-aspartate receptor antibodies in postherpes simplex virus encephalitis neurological relapse. Mov Disord 2013; 29:90-96.
51. Mohammad SS, Sinclair K, Pillai S, et al. Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-methyl-D-aspartate receptor or dopamine-2 receptor. Mov Disord 2013; 29:117-122.
52. Hargrave DR, Webb DW. Movement disorders in association with herpes simplex virus encephalitis in children: a review. Dev Med Child Neurol 1998; 40:640-642.
53. Titulaer MJ, Leypoldt F, Dalmau J. Antibodies to N-methyl-D-aspartate and other synaptic receptors in choreoathetosis and relapsing symptoms postherpes virus encephalitis. Mov Disord 2014; 29:3-6.
54. De Tiège X, Rozenberg F, Des Portes V, et al. Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology 2003; 61:241-243.
55. Höftberger R, Armangue T, Leypoldt F, et al. Clinical neuropathology practice guide 4-2013: postherpes simplex encephalitis, N-methyl-D-aspartate receptor antibodies are part of the problem. Clin Neuropathol 2013; 32: 251-254.
56. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2013; 13:167-177.
57. Titulaer MJ, Hö ftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. Ann Neurol 2014. [Epub ahead of print]